[Heart assist (Vilnius University experience)]

Saulius Miniauskas1, Kestutis Rucinskas, Gintaras Rasimavicius

  • 1Heart Surgery Center, Vilnius University, Santariskiu 2, 2021 Vilnius, Lithuania. cardiosurgery@omni.lt

Insights

Mechanical heart assist devices improve outcomes for patients with advanced heart failure. Intra-aortic balloon pumps show 53% success, while Berlin Heart ventricles offer effective long-term support and bridge to transplantation.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Despite advances in heart surgery, end-stage heart failure remains a significant challenge.
  • Mechanical heart assist devices are crucial for managing patients awaiting or recovering from cardiac procedures.
  • These devices address hemodynamic compromise in post-cardiotomy and post-transplant patients.

Purpose of the Study:

  • To evaluate the efficacy of different mechanical heart assist strategies at the Vilnius University Heart Surgery Center.
  • To compare outcomes of intra-aortic balloon pump, extracorporeal membrane oxygenation, and artificial ventricles.

Main Methods:

  • Retrospective analysis of 856 patients treated with intra-aortic balloon pumps (IABP) using various insertion techniques.
  • Review of 8 patients receiving extracorporeal membrane oxygenation (ECMO) for critical heart and respiratory failure.
  • Analysis of 15 Berlin Heart artificial ventricles implanted in 13 patients between 1999 and 2003.

Main Results:

  • IABP success rate was 53% overall, with best outcomes (67% discharge) after aorta-coronary bypass surgery.
  • IABP success was lower (28%) in heart transplant patients.
  • ECMO showed limited success with only 1 of 8 patients successfully weaned.
  • Berlin Heart ventricles demonstrated effectiveness as a bridge to transplantation and for long-term support, with 6 patients transplanted and one living over 2 years.

Conclusions:

  • Intra-aortic balloon pump is an established and effective method for heart assist, particularly post-CABG.
  • Extracorporeal membrane oxygenation has limited application due to low success rates in this cohort.
  • Artificial Berlin Heart ventricles represent a promising and effective option for long-term circulatory support and as a bridge to heart transplantation.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.